PrEP Affect Regulation Treatment Innovation

NAActive, not recruitingINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

February 1, 2026

Study Completion Date

July 1, 2026

Conditions
Medication AdherenceHIV PreventionStimulant Use
Interventions
BEHAVIORAL

PARTI

PARTI will provide positive affect skills. Each 1-hour session delivered via Zoom consists of a didactic portion with in vivo skills practice and participants are asked to complete home practice of the skills between sessions. Many sessions include formal exercises that have been utilized in Mindfulness-Based Relapse Prevention to cultivate mindfulness and meta-cognitive awareness.

BEHAVIORAL

Attention-Control

Attention-Control will provide a core set of coping and affect measures as well as neutral writing exercises. Each 1-hour attention-control session will be administered via Zoom.

BEHAVIORAL

Contingency Management for PrEP Adherence

Participants will complete a 12-week contingency management protocol via their smartphone that consists of uploading brief videos taking PrEP medications up to four times per week. Total possible contingency management incentive for completing 48 observed PrEP doses is $360.

Trial Locations (2)

33136

University of Miami Miller School of Medicine, Miami

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Florida International University

OTHER